The original use of “Business As Usual” was during wartime, a deliberate attempt to maintain public calm while the world collapsed around them. So the question is this: What war, exactly, is the FSA trying to normalise? Against transparency, perhaps? If that is the case, it's interesting that it started at a time that is significant for CBD Novel Foods. That is provable through the 2021 FSA FOI report, which, other than a modified response on 17/06/21, shows an abrupt stop

The 10mg ADI simply does not hold up, even for synthetic CBD, especially if a 300UF is likely excessive. Furthermore, the FSA’s exclusion of

Regardless of the intent, is it right that the FSA stops, or targets companies for changing their labels to reflect consumer information tha

Escalation - a preview of The Hemp Hound Agency's meeting with the FSA to discuss the Public Interest Disclosure Complaint against their han

In the early days of January this year, it became apparent that the FSA were working towards the first applications to be adjudicated for pr

From The Hemp Hound Agency On 12/05/23 the Food Standards Agency (FSA) responded to a complaint that was lodged on 15/07/22 in regards to...

I'm not saying that all of the events reported are associated with Sativex, Epidiolex and whatever other preparations have been trialled and

Have the Home Office dictated the direction of Novel Foods for CBD products? It's definitely a possibility, both in 2017 AND 2019!

This is The Hemp Hound Agency's investigation into Deloitte, who were awarded a contract by the Food Standards Agency to review Novel Foods

How is Novel Foods, the 'recreational vs medicinal' debate, and the Home Office's clampdown on drug use connected? By the TIGRR report!

The issues with legalisation are that whilst you can have access to the plant, it's still under someone else's terms. But are those terms ac

On the 19th of August, the Hemp Hound Agency received a reply from the FSA in regards to a submitted PID sent to them on the 15th of July th

It's time to whistleblow against the FSA on behalf of the Hemp and CBD industry, there is blatantly a level of corruption that needs to be e

0.69% of the Novel Foods list is validated, yet just under half of them shouldn't be.

It's been hard for me to suss out what to write about Alison Hernandez's opinion in regards to the classification of cannabis, as I'd contac